| Literature DB >> 35681810 |
Alexandra Chiaverini1, Alessandra Cornacchia1, Gabriella Centorotola1, Elga Ersilia Tieri1, Nadia Sulli1, Ilaria Del Matto1, Giorgio Iannitto1, Domenico Petrone1, Antonio Petrini1, Francesco Pomilio1.
Abstract
Despite Klebsiella pneumoniae being widely recognized as a nosocomial pathogen, there is a critical lack in defining its reservoirs and sources of infections. Most studies on risk factors have focused on multidrug-resistant (MDR) isolates and clinically-oriented questions. Over a two-year period, we sampled 131 wild animals including mammal and bird species from three regions of Central Italy. All typical colonies isolated from the analytical portions were confirmed by real-time PCR and identified by MALDI-TOF mass spectrometry (MALDI-TOF MS). All confirmed K. pneumoniae isolates were tested for antimicrobial susceptibility to 29 antimicrobials and subjected to whole genome sequencing. Typical colonies were detected in 17 samples (13%), which were identified as K. pneumoniae (n = 16) and as K. quasipneumoniae (n = 1) by MALDI-TOF MS. The antimicrobial susceptibility profile showed that all the isolates were resistant to β-lactams (ceftobiprole, cloxacillin, cefazolin) and tetracycline; resistance to ertapenem and trimethoprim was observed and nine out of 16 K. pneumoniae isolates (56.2%) were classified as MDR. Genomic characterization allowed the detection of fluoroquinolone resistance-associated efflux pumps, fosfomycin and β-lactamase resistance genes, and virulence genes in the overall dataset. The cluster analysis of two isolates detected from wild boar with available clinical genomes showed the closest similarity. This study highlights the link between humans, domestic animals, and wildlife, showing that the current knowledge on this ecological context is lacking and that the potential health risks are underestimated.Entities:
Keywords: K. pneumoniae; antimicrobial resistance; whole genome sequencing; wildlife
Year: 2022 PMID: 35681810 PMCID: PMC9179660 DOI: 10.3390/ani12111347
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Figure 1K. pneumoniae positive (red) and negative (green) samples isolated from wild animals in the Abruzzo, Molise, and Lazio regions.
Metadata of 17 strains used in this study.
| ID | Year | Host | Matrix |
|---|---|---|---|
| 2021.TE.2 | 2020 | Wild boar | Feces |
| 2021.TE.3 | 2020 | Fallow deer | Feces |
| 2021.TE.4 | 2020 | Fallow deer | Feces |
| 2021.TE.5 | 2020 | Roe deer | Feces |
| 2021.TE.6 | 2020 | Roe deer | Feces |
| 2021.TE.7 | 2020 | Red deer | Feces |
| 2021.TE.8 | 2020 | Red deer | Feces |
| 2021.TE.9 | 2020 | European badger | Small intestine |
| 2021.TE.10 | 2020 | European badger | Feces |
| 2021.TE.11 | 2020 | Magpie | Small intestine |
| 2021.TE.12 | 2020 | Red fox | Small intestine |
| 2021.TE.13 | 2020 | Wolf | Feces |
| 2021.TE.15 | 2020 | Wild boar | Brain |
| 2021.TE.17 | 2020 | Wild boar | Small intestine |
| 2021.TE.18 | 2021 | Wild boar | Brain |
| 2021.TE.19 | 2021 | Wild boar | Brain |
| 2021.TE.20 | 2021 | Wild boar | Brain |
Genomic characterization of 17 Klebsiella spp. strains analyzed in this study. ST: sequence type, KL: K locus, O: O locus, β-lactams: beta-lactams, Tet: tetracycline, Sul: sulfonamides, Ami: aminoglycosides, Ybt: yersiniabactin, Clb: colibactin, Iuc: aerobactin, Iro: salmochelin, rmpA: hypermucoid genes.
| ID | ST | KL | O | β-Lactams |
|
| Ami | Plasmid | Ybt | Clb | Iuc | Iro | rmpA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021.TE.2 | 133 | KL116 | O1v1 | SHV-75 | / | / | / | IncFIB(K) | ybt 9 | / | unknown | / | / |
| 2021.TE.3 | 301 | KL116 | O2v1 | SHV-27 | / | / | / | / | / | / | / | / | / |
| 2021.TE.4 | 301 | KL116 | O2v1 | SHV-27 | / | / | / | / | / | / | / | / | / |
| 2021.TE.5 | *5670 | KL30 | O3/O3a | SHV-11 | / | / | / | / | / | / | / | / | / |
| 2021.TE.6 | 2217 | KL13 | O3b | SHV-1 | / | / | / | / | / | / | / | / | / |
| 2021.TE.7 | *ca55 | KL30 | O1v1 | SHV-65 | / | / | / | IncFIB(K) | ybt 9 | / | iuc 3 | / | / |
| 2021.TE.8 | 200 | *KL13 | O3b | SHV-1 | / | / | / | / | / | / | / | / | / |
| 2021.TE.9 | 162 | KL13 | O3b | SHV-1 | / | / | / | / | ybt 16 | / | / | / | / |
| 2021.TE.10 | 4895 | KL35 | O3/O3a | OKP-A-2 | / | / | / | IncFIB(K) | / | / | / | / | / |
| 2021.TE.11 | 277 | / | O3b | SHV-27 | / | / | / | IncFIB(K), | / | / | / | / | / |
| 2021.TE.12 | 219 | KL121 | O1v1 | SHV-1 | / | / | / | IncFIB(AP001918) | ybt 16 | / | iuc 3 | / | / |
| 2021.TE.13 | 116 | KL11 | O3/O3a | SHV-1 | / | / | / | / | / | / | / | / | / |
| 2021.TE.15 | *fc60 | KL117 | O2v2 | SHV-11 | / | / | / | IncFIB(pKPHS1) | / | / | / | / | / |
| 2021.TE.17 | 23 | KL1 | O1v2 | SHV-11 | / | / | / | repB (pK2044) | ybt 1 | clb 2 | iuc 1 | iro1 | rmpA1 |
| 2021.TE.18 | 35 | KL22 | O1v1 | SHV-33 | tetA | sul2 | strA | IncFIB(pKPHS1) | ybt 5 | / | iuc 3 | / | / |
| 2021.TE.19 | 3071 | KL31 | OL104 | SHV-27 | / | / | / | IncFIB(pKPHS1) | / | / | iuc 3 | / | / |
| 2021.TE.20 | 3071 | KL31 | O3b | SHV-27 | / | / | / | IncFIB(pKPHS1) | / | iuc 3 | / | / |
Figure 2Heatmap encompassing antimicrobial susceptibility testing results of K. pneumoniae strains (blue) and K. quasipneumionae strain (green). Red color indicates resistance, yellow indicates an intermediate phenotype, and white indicates susceptibility. AMP: ampicillin, POD: cefpodoxime, CD: cefpodoxime-clavulanic acid, P/T4:piperacillin-tazobactam constant 4, FOX: cefoxitin, BPR: ceftobiprole, AZT: aztreonam, ETP: ertapenem, MERO: meropenem, AMI: amikacin, GEN: gentamicin, NET: netilmicin, TOB: tobramycin, KAN: kanamycin, CIP: ciprofloxacin, NAL: nalidixic acid, TMP: trimethoprim, SXT: trimethoprim-sulfamethoxazole, CLO: cloxacillin, TET: tetracycline, A/S2: ampicillin-sulbactam, FAZ: cefazolin, FEP: cefepime, TAZ: ceftazidime, AXO: ceftriaxone, FUR: cefuroxime, TIM2: ticarcillin-clavulanic acid constant 2, TGC: tigecycline.
Figure 3Neighbor joining (NJ) tree resulting from the cgMLST analysis performed on the 16 K. pneumoniae draft assemblies according to the Pasteur Institute’s scheme (629 loci). The tree is annotated with metadata (source and year of isolation), antimicrobial resistance gene (blue color indicates the presence), virulence score, virulence genes (red color indicates the presence), and plasmid (grey color indicates the presence). For novel sequence types we attributed the symbol “*”.
Figure 4Cluster analysis performed with public genomes available on Pathogenwatch platform. (a) Core-genome MLST (cgMLST) analysis of the isolate 2021.TE.17 with 45 available clinical genomes belonging to the ST23. In the red circle are highlighted the ST23 public genomes carrying carbapenemase resistance genes. (b) cgMLST analysis of isolate 2021.TE.18 with four clinical genomes (ERR1217151, SRR5386627, SRR10058597, and ERR1541571). In the branches it is reported the numbers of allelic differences.